Obstetric Pain Management for Women With Opioid Use Disorder (QUEST)
QUEST
1 other identifier
observational
33
1 country
1
Brief Summary
This is a mixed methods longitudinal observational study to assess patient and provider perspectives on pain and pain management among pregnant women with opiate use disorder (OUD). The findings from this study will inform patient-centered approaches to pain management. Themes surrounding mothers' pain/recovery experiences that correlate with quantified pain and analgesia endpoints will be identified. Findings will also shape an appropriate patient-centered research agenda for obstetric pain management in patients with OUD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2020
CompletedStudy Start
First participant enrolled
March 6, 2020
CompletedFirst Posted
Study publicly available on registry
March 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2022
CompletedApril 7, 2022
April 1, 2022
1.2 years
March 6, 2020
April 6, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Themes surrounding mothers' pain/recover experience
The endpoint of this mixed-methods investigation is to identify themes surrounding mothers' pain/recovery experiences that correlate with quantified pain and analgesic needs. Endpoint will take the form of words/terms, phrases, or sentences. Identification of these terms, phases, or sentences are not identified a priori in this qualitative investigation.
Through study completion, an average of 6 weeks (from enrollment through labor and delivery)
Study Arms (2)
Patient participants
This cohort will include pregnant patients with a history of opiate use disorder (OUD) who will be followed from the third trimester of pregnancy until five days postpartum.
Provider participants
This cohort will include clinicians who provide care for pregnant patients with OUD. Providers will be interviewed and will complete one survey cross-sectionally.
Interventions
Eligibility Criteria
This study will enroll pregnant adults with opiate use disorder (on medication assisted therapy) who are currently in their third trimester.
You may qualify if:
- Pregnant women who are 18 years of age or older
- History of opioid use disorder, on medication assisted therapy
- Currently in their third trimester
You may not qualify if:
- Unable to participate in informed consent discussions
- Unable to give informed consent for any reason
- Not fluent in English (surveys are validated in English language)
- Unable to participate fully in all study procedures for any reason
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UPMC Magee Womens Hospital
Pittsburgh, Pennsylvania, 15215, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Grace Lim, MD MS
University of Pittsburgh
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Primary Investigator
Study Record Dates
First Submitted
March 6, 2020
First Posted
March 16, 2020
Study Start
March 6, 2020
Primary Completion
May 1, 2021
Study Completion
March 31, 2022
Last Updated
April 7, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share